EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation

Zhi Yang, Bin Deng, Tian Sun, Yongqin Wang, Wei Dong, Junfei Jin, Zhixiong Pan

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl46946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Zhi Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, G…. Hauptthemen laut MEDLINE: Exosomes, Reperfusion Injury, Hepatocytes, Liver. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi, Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department, Lijiang Scholar Award in Guilin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Exosomes are specialized secreted vesicles for intercellular communication and signaling pathways as specialized secreted vesicles. Multiple studies have suggested the potential roles of hepatocyte-derived exosomes as biomarkers of liver injury and facilitators of hepatocyte proliferation and liver regeneration.

Methods

By utilizing murine models of hepatic ischemia-reperfusion injury (IRI), we examined the impact of hepatocyte-derived exosomes on mitigating hepatic IRI.

Results

Our experiments have demonstrated that significantly lower levels of alanine transaminase, aspartate transaminase, and lactate dehydrogenase in mice treated with hepatocyte-derived exosomes compared with mice treated with phosphate-buffered saline (PBS). Furthermore, hepatocyte-derived exosomes inhibited hepatocyte apoptosis, reduced levels of inflammatory cytokines, and suppressed the entry of inflammatory cells into the liver following hepatic IRI. Complement 3d (C3d) expression showed a notable decrease in exosome-treated mice compared with PBS-treated mice, suggesting that hepatocyte-derived exosomes effectively inhibited complement activation during hepatic IRI. Blocking the fusion of exosomes with cells using Annexin V weakened the protective effects of the exosomes against hepatic IRI.

Conclusions

Our findings highlight the ability of hepatocyte-derived exosomes to mitigate hepatic IRI by inhibiting complement activation. These results reveal a novel role for exosomes in blocking complement activation, suggesting a potential new therapeutic avenue for preventing hepatic IRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesReperfusion InjuryHepatocytesLiverComplement ActivationLiver DiseasesAnimalsMiceMaleApoptosisMice, Inbred C57BLCytokines

Stichwörter der Autor:innen

apoptosiscomplementexosomeshepatic ischemia reperfusion injury

Substanzen

Cytokines

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.
  • Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.
  • China-USA Lipids in Health and Disease Research Center, Guilin Medical University, 541001 Guilin, Guangxi, China.
  • Laboratory of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.

Förderung

  • Natural Science Foundation of Guangxi
  • Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department
  • Lijiang Scholar Award in Guilin
  • Science and Technology Planned Project in Guilin
  • Medical High Level Talents Training Plan in Guangxi
  • Construction Fund of Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases (the Affiliated Hospital of Guilin…
  • Guangxi Medical and Health Key Discipline Construction Project
  • Construction Fund of Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases

Zitieren

APA

Yang, Z., Deng, B., Sun, T., Wang, Y., Dong, W., Jin, J., & Pan, Z. (2025). Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46946

Vancouver

Yang Z, Deng B, Sun T, Wang Y, Dong W, Jin J, et al. Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46946

BibTeX
@article{Yang2025,
  author = {Yang, Zhi and Deng, Bin and Sun, Tian and Wang, Yongqin and Dong, Wei and Jin, Junfei and Pan, Zhixiong},
  title = {Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl46946}
}
Kostenlos starten →